These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1334113)

  • 1. Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs.
    Parchment RE; Soleimanpour K; Petrose S; Murphy MJ
    Int J Cell Cloning; 1992 Nov; 10(6):359-68. PubMed ID: 1334113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of in vitro chemosensitivity assays: human tumor clonogenic and scintillation assay].
    Tanigawa N; Morimoto H; Akita T; Inoue H; Tanaka T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1176-84. PubMed ID: 3729439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T; Kuraishi Y; Aiba K; Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
    Long BH; Wang L; Lorico A; Wang RC; Brattain MG; Casazza AM
    Cancer Res; 1991 Oct; 51(19):5275-83. PubMed ID: 1717144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fundamental study and clinical testing of human tumor clonogenic assay (HTCA)].
    Sasaki Y; Saijo N; Eguchi K; Futami H; Suga J; Miyaoka H; Sano T; Sakurai M; Shinkai T; Tominaga K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1185-93. PubMed ID: 3729440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
    Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
    Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin.
    Kim R; Hirabayashi N; Nishiyama M; Saeki S; Toge T; Okada K
    Anticancer Res; 1991; 11(1):429-31. PubMed ID: 1850221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update of human tumor clonogenic assay in carcinoma of the lung].
    Kanzawa F
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
    Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro drug-sensitivity test using human tumor clonogenic assay in lung cancer patients].
    Ohnoshi T; Hiraki S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1582-7. PubMed ID: 3927847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Choice of second-line chemotherapy for advanced breast cancer based on the chemosensitivity assay by in vitro colony assay].
    Inoue K; Mukaiyama T; Yamazaki H; Horikoshi N; Ogawa M; Kobayashi T; Aiba K; Kuraishi Y
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):356-61. PubMed ID: 3080968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
    Cole SP; Chanda ER; Dicke FP; Gerlach JH; Mirski SE
    Cancer Res; 1991 Jul; 51(13):3345-52. PubMed ID: 1675932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the human tumor stem cell assay to study chemotherapy sensitivity in cancer of the cervix.
    Parker RL; Welander CE; Homesley HD; Jobson VW; Kawamoto EH
    Obstet Gynecol; 1984 Sep; 64(3):412-6. PubMed ID: 6462571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modalities of resistance in etoposide-resistant human KB cell lines.
    Ferguson PJ; Fisher MH; Stephenson J; Li DH; Zhou BS; Cheng YC
    Cancer Res; 1988 Nov; 48(21):5956-64. PubMed ID: 2844393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells.
    Wolverton JS; Danks MK; Schmidt CA; Beck WT
    Cancer Res; 1989 May; 49(9):2422-6. PubMed ID: 2539902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
    Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
    Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonogenic and nonclonogenic in vitro chemosensitivity assays.
    Weisenthal LM; Lippman ME
    Cancer Treat Rep; 1985 Jun; 69(6):615-32. PubMed ID: 3893692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.